1. Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
    Tiantian Li et al, 2022, Nutrients CrossRef
  2. Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson’s disease
    Jessica Grigoletto et al, 2023, npj Parkinson's Disease CrossRef
  3. Exploring Therapeutic Potential of Phytoconstituents as a Gut Microbiota Modulator in the Management of Neurological and Psychological Disorders
    Prarit Chandel et al, 2024, Neuroscience CrossRef
  4. Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
    Margherita Alfonsetti et al, 2022, Nutrients CrossRef
  5. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
    Kenneth Maiese, 2023, Frontiers in Immunology CrossRef
  6. Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial
    Alireza Zali et al, 2024, Psychopharmacology CrossRef
  7. IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes
    Eric L. Brown et al, 2023, Journal of Parkinson's Disease CrossRef
  8. Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
    Kenneth Maiese, 2023, Cells CrossRef
  9. Zeolite and Neurodegenerative Diseases
    Stefan Panaiotov et al, 2024, Molecules CrossRef
  10. Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut–microbiota–brain axis
    Yaoyu Pu et al, 2023, Psychopharmacology CrossRef
  11. METTL14 is decreased and regulates m6A modification of α‐synuclein in Parkinson's disease
    Honghu He et al, 2023, Journal of Neurochemistry CrossRef
  12. Editorial: The Role of the Microbiome in Regulating T-Cell Response in Asthma and Food Allergy
    Ayşe Kiliç et al, 2021, Frontiers in Immunology CrossRef
  13. Revisiting Alpha-Synuclein Pathways to Inflammation
    Patrícia Lyra et al, 2023, International Journal of Molecular Sciences CrossRef
  14. Crosstalk between gut–brain axis: unveiling the mysteries of gut ROS in progression of Parkinson’s disease
    Divya Soni et al, 2024, Inflammopharmacology CrossRef
  15. Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer’s disease
    Sunil Thomas et al, 2023, Frontiers in Pharmacology CrossRef
  16. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
    Júlio César Claudino dos Santos et al, 2023, Ageing Research Reviews CrossRef
  17. Cognitive Impairment in Multiple Sclerosis
    Kenneth Maiese, 2023, Bioengineering CrossRef
  18. Effects of Gut Microbiota Alterations on Motor, Gastrointestinal, and Behavioral Phenotype in a Mouse Model of Parkinson’s Disease
    Nina Radisavljevic et al, 2022, Journal of Parkinson's Disease CrossRef
  19. The Metabolic Basis for Nervous System Dysfunction in Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease
    Kenneth Maiese, 2023, Current Neurovascular Research CrossRef
  20. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
    Nasir Uddin Mahbub et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef
  21. Bacillus amyloliquifaciens-Supplemented Camel Milk Suppresses Neuroinflammation of Autoimmune Encephalomyelitis in a Mouse Model by Regulating Inflammatory Markers
    Hairul Islam Mohamed Ibrahim et al, 2023, Nutrients CrossRef
  22. Does gut brain axis has an impact on Parkinson’s disease (PD)?
    Ajay Elangovan et al, 2024, Ageing Research Reviews CrossRef